נובוסבן אר.טי  2 מג בקבוקון ישראל - עברית - Ministry of Health

נובוסבן אר.טי 2 מג בקבוקון

novo nordisk ltd., israel - eptacog alfa (activated) - אבקה להכנת תמיסה לזריקה - eptacog alfa (activated) 2 mg/vial - eptacog alfa (activated) - eptacog alfa (activated) - treatment of bleeding episodes and prevention of bleeding in those undergoing surgery of invasive procedures in the following patient goups : * in patients with congenital haemophilia with inhibitors to coagulation factors viii or ix > 5 bu, * in patients with congenital haemophilia who are expected to have a high anamnestic response to factor viii or factor ix administration, * in patients with acquired haemophilia, in patients with congenital fvii deficieny, * in patients with glanzmann's thropnbastenia with antibodies to gp iib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.

נובוסבן אר.טי  5 מג בקבוקון ישראל - עברית - Ministry of Health

נובוסבן אר.טי 5 מג בקבוקון

novo nordisk ltd., israel - eptacog alfa (activated) - אבקה להכנת תמיסה לזריקה - eptacog alfa (activated) 5 mg/vial - eptacog alfa (activated) - eptacog alfa (activated) - treatment of bleeding episodes and prevention of bleeding in those undergoing surgery of invasive procedures in the following patient goups : * in patients with congenital haemophilia with inhibitors to coagulation factors viii or ix > 5 bu, * in patients with congenital haemophilia who are expected to have a high anamnestic response to factor viii or factor ix administration, * in patients with acquired haemophilia, in patients with congenital fvii deficieny, * in patients with glanzmann's thropnbastenia with antibodies to gp iib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.

ורילריקס ישראל - עברית - Ministry of Health

ורילריקס

glaxo smith kline (israel) ltd - varicella virus, live attenuated - אבקה וממס להכנת תמיסה להזרקה - varicella virus, live attenuated nlt 10^3.3 pfu - varicella zoster vaccines - in the event of negative anamnesis, for the active immunisation against varicella in healthy subjects only from the age of 12 months.

Therapeutic Pneumatic compression Systems ישראל - עברית - Ministry of Health

therapeutic pneumatic compression systems

mego afek ac ltd. - כלל האוכלוסיה - primary lymphedema, secondary lymphedema, venous insufficiency, venous disorders & dysfunction of the muscle pump

Covidien / KENDALL- ARGYLE Products according to list ישראל - עברית - Ministry of Health

covidien / kendall- argyle products according to list

קובידיאן (ישראל) בע"מ - מומחה - esophageal/ tracheal tubes and hemodialysis/ peritoneal/ central venous catheters and related accessories-

AVfloTM VASCULAR ACCESS GRAFT ישראל - עברית - Ministry of Health

avflotm vascular access graft

nicast ltd. - מומחה - the avflotm vascular access graft’s proposed indication for use is as a subcutaneous, arteriovenous conduit for blood access

ETView VivaEB (endobronchial blocker) ישראל - עברית - Ministry of Health

etview vivaeb (endobronchial blocker)

etview ltd. - רופא - the etview viva eb is used to isolate the left or right lung of a patient for surgery, one lung ventilation or one lung anesthesia

ETView VivaSight DL ישראל - עברית - Ministry of Health

etview vivasight dl

etview ltd. - רופא - the etview vivasight dl is intended to isolate the left or right lung of a patient for intensive care or surgery, one lung ventilation or one lung anesthesia. the vivasight dl system is indicated for verifying tube placement and repositioning.

EV3 Products - see list ישראל - עברית - Ministry of Health

ev3 products - see list

חברת אינומדיקה טכנולוגיות רפואיות בע"מ - מומחה - tile marksman™ catheter is intended for the introduction of in terventiona 1 devices and infusion of diagnostic or therapeutic agents into the neuro, peripheral and coronary vasculature,

Perfadex + silicon tubing set ישראל - עברית - Ministry of Health

perfadex + silicon tubing set

מעבדות רפא בע"מ - אחר - perfadex solution is indicated for the flushing, storage and transportation of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient